The Vanguard Group 13D/13G Filings for Avenue Therapeutics, Inc. (ATXI)

The Vanguard Group 13D and 13G filings for Avenue Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-09
3:24 pm
Sale
2021-12-3113GAvenue Therapeutics, Inc.
ATXI
The Vanguard Group402
2.420%
-433decrease
(-51.83%)
Filing